Le Lézard
Classified in: Health, Science and technology
Subject: PDT

CEFALY Migraine Device is Now Available in Canada Direct to Consumer


 

CEFALY Technology is the manufacturer and now also the exclusive distributor of the CEFALY device and its accessories across the country

NEW YORK, Jan. 14, 2020 /PRNewswire/ -- CEFALY Technology is pleased to announce that their latest technology for the drug-free treatment of migraines, the CEFALY DUAL device, and its accessories are now available across Canada direct to consumer. Until recently, only the original CEFALY device was available to migraineurs in Canada and it was sold via distributor.

"We are excited to start the New Year on a new path," said Jennifer Trainor-McDermott, CEO with CEFALY Technology. "We are developing very focused initiatives to help migraineurs across Canada access relief and more quickly. This strategic move to relocate distribution in-house will provide more flexibility to meet our growing demand."

CEFALY has rapidly become a global brand, widely recognized among the migraine community, which is estimated to be around 1 billion worldwide1. The CEFALY device is the first FDA-cleared medical technology of its kind for the treatment of migraine headaches. It is a non-invasive device placed on the forehead that uses two distinct programs (ACUTE and PREVENT) to stimulate and desensitize the area research identifies as a center for migraine pain, the Trigeminal nerve. Since CEFALY is not a drug, it can be used as a standalone option or with an existing treatment. Patients who use the device consistently show a decrease in migraine days and in intake of migraine medication.

In addition to gaining access to CEFALY's latest technology, consumers in Canada will experience the company's newly refreshed brand and web presence: https://www.cefaly.com/en-ca

About CEFALY Technology
CEFALY Technology is a Belgium-based company, with US offices based in Wilton, Connecticut, specializing in electronics for medical applications. It has developed external cranial stimulation technology for applications in the field of neurology; in particular for treating migraines.

For more information about CEFALY Technology visit: https://www.cefaly.us.
For more information on purchasing CEFALY in Canada visit: https://www.cefaly.com/en-ca.

Sources

1 Migraine facts. American Migraine Foundation website. Accessed January 13, 2020

Media Contact: Maria Coder
[email protected]

SOURCE CEFALY Technology


These press releases may also interest you

at 18:03
Ferrovial has teamed up with U.S. technology consulting firm DXC Technology to jointly develop the platform known as Quercus to accelerate and scale the adoption of Generative Artificial Intelligence (AI) across the infrastructure company's...

at 18:00
KCD PR, a full-service strategic communications and marketing agency with deep roots in web3, blockchain and financial services, announced today a custom service offering curated for brands participating at CoinDesk Consensus 2024. The conference...

at 17:56
Total Play Telecomunicaciones, S.A.P.I. de C.V. ("Total Play"), a leading telecommunications company in Mexico, which offers internet access, pay television and telephony services, through one of the...

at 17:46
Kitco Metals Inc. has established itself as a leading authority within the precious metals sector and is now acknowledged, by its employees, as one of the best places to work in Canada....

at 17:34
Payfare Inc. ("Payfare" or the "Company") , a leading fintech powering instant payout and digital banking solutions for workforces, today announced summarized unaudited results for the fourth quarter and year ending December 31, 2023. Unaudited Q4...

at 17:33
Neowrk, a startup that has developed advanced and unique hardware, software, and artificial intelligence technology to optimize workspace management, is receiving a R$ 10 million investment in a round led by Indicator Capital with R$ 8 million,...



News published on and distributed by: